ID   AH130
AC   CVCL_4367
SY   Yoshida AH-130; Yoshida AH130; AH-130; AH 130; AH-130 Yoshida; AH130-TC; AH130/P
DR   BTO; BTO:0000593
DR   CLS; 500412/p644_AH-130
DR   TKG; TKG 0530
DR   Wikidata; Q54748762
RX   PubMed=710800;
RX   PubMed=13549114;
RX   PubMed=14247586;
CC   Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from metastatic site: Ascites.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 24-05-19; Version: 13
//
RX   PubMed=710800; DOI=10.20772/cancersci1959.74.2_240;
RA   Kohga S.;
RT   "Thromboplastic and fibrinolytic activities of ascites tumor cells of
RT   rats, with reference to their role in metastasis formation.";
RL   Gann 69:461-470(1978).
//
RX   PubMed=13549114;
RA   Takaoka T., Katsuta H.;
RT   "Establishment of cell strains of rat ascites hepatoma cells in tissue
RT   culture.";
RL   Jpn. J. Exp. Med. 28:115-127(1958).
//
RX   PubMed=14247586; DOI=10.20772/cancersci1959.55.5_363;
RA   Hirono I., Kojima K., Kachi H., Ohashi A., Sasaoka I.;
RT   "Development of free-cell sublines of the ascites hepatoma AH-130 and
RT   their biological properties.";
RL   Gann 55:363-372(1964).
//